Tags

Type your tag names separated by a space and hit enter

Tension-free vaginal tape obturator: midterm data on an operative procedure for the cure of female stress urinary incontinence performed on 100 patients.
J Minim Invasive Gynecol. 2008 Jan-Feb; 15(1):92-6.JM

Abstract

STUDY OBJECTIVE

To evaluate the midterm therapeutic results of a minimally invasive anti-incontinence operative procedure, the tension-free vaginal tape (TVT) obturator.

DESIGN

With this prospective, observational, and consecutive patient series, the TVT obturator procedure was performed by the same surgeon on 100 patients. Follow-up lasted 30 to 36 months.

SETTING

Operative theaters of Assuta medical centers private hospitals.

PATIENTS

One hundred female patients with urodynamically proven stress urinary incontinence.

INTERVENTIONS

TVT obturator operations were performed for all patients.

MEASUREMENTS AND MAIN RESULTS

Demographic and therapeutic aspects of the patient group data were evaluated. Clinical signs for bowel, urethral, or bladder injuries were undetectable with this TVT obturator patient group. Intraoperative bleeding, postoperative field infections, or postoperative pelvic floor relaxations were not noted. The therapeutic failure rate for the TVT obturator procedure was 8.0% (8 of 100 patients) after 1 year, whereas the midterm failure rate was 10.8% (10 of 93 patients). Six of the 10 patients with TVT obturator failure underwent interval TVT operations with satisfactory results. The overall midterm satisfaction rate for this study group of patients was 89.2% (83 of 93 patients), 6 (6.5%) of those patients were improved only, yet still with minimal residual urinary leakage.

CONCLUSION

Use of the TVT obturator, a midurethral sling, did not involve bladder penetration and was complicated by a low rate of postoperative outlet obstruction. The midterm therapeutic results and the cost-effectiveness of the TVT obturator appear similar to previously reported midurethral sling operations. Long-term comparative data collection is required to enable drawing solid conclusions regarding the appropriate position of this operative technique within the spectrum of antiincontinence operations.

Authors+Show Affiliations

Urogynecology, Department of Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel. mneuman@netvision.net.il

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18262152

Citation

Menahem, Neuman. "Tension-free Vaginal Tape Obturator: Midterm Data On an Operative Procedure for the Cure of Female Stress Urinary Incontinence Performed On 100 Patients." Journal of Minimally Invasive Gynecology, vol. 15, no. 1, 2008, pp. 92-6.
Menahem N. Tension-free vaginal tape obturator: midterm data on an operative procedure for the cure of female stress urinary incontinence performed on 100 patients. J Minim Invasive Gynecol. 2008;15(1):92-6.
Menahem, N. (2008). Tension-free vaginal tape obturator: midterm data on an operative procedure for the cure of female stress urinary incontinence performed on 100 patients. Journal of Minimally Invasive Gynecology, 15(1), 92-6. https://doi.org/10.1016/j.jmig.2007.10.012
Menahem N. Tension-free Vaginal Tape Obturator: Midterm Data On an Operative Procedure for the Cure of Female Stress Urinary Incontinence Performed On 100 Patients. J Minim Invasive Gynecol. 2008 Jan-Feb;15(1):92-6. PubMed PMID: 18262152.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tension-free vaginal tape obturator: midterm data on an operative procedure for the cure of female stress urinary incontinence performed on 100 patients. A1 - Menahem,Neuman, PY - 2007/10/21/received PY - 2007/10/21/revised PY - 2007/10/29/accepted PY - 2008/2/12/pubmed PY - 2008/5/14/medline PY - 2008/2/12/entrez SP - 92 EP - 6 JF - Journal of minimally invasive gynecology JO - J Minim Invasive Gynecol VL - 15 IS - 1 N2 - STUDY OBJECTIVE: To evaluate the midterm therapeutic results of a minimally invasive anti-incontinence operative procedure, the tension-free vaginal tape (TVT) obturator. DESIGN: With this prospective, observational, and consecutive patient series, the TVT obturator procedure was performed by the same surgeon on 100 patients. Follow-up lasted 30 to 36 months. SETTING: Operative theaters of Assuta medical centers private hospitals. PATIENTS: One hundred female patients with urodynamically proven stress urinary incontinence. INTERVENTIONS: TVT obturator operations were performed for all patients. MEASUREMENTS AND MAIN RESULTS: Demographic and therapeutic aspects of the patient group data were evaluated. Clinical signs for bowel, urethral, or bladder injuries were undetectable with this TVT obturator patient group. Intraoperative bleeding, postoperative field infections, or postoperative pelvic floor relaxations were not noted. The therapeutic failure rate for the TVT obturator procedure was 8.0% (8 of 100 patients) after 1 year, whereas the midterm failure rate was 10.8% (10 of 93 patients). Six of the 10 patients with TVT obturator failure underwent interval TVT operations with satisfactory results. The overall midterm satisfaction rate for this study group of patients was 89.2% (83 of 93 patients), 6 (6.5%) of those patients were improved only, yet still with minimal residual urinary leakage. CONCLUSION: Use of the TVT obturator, a midurethral sling, did not involve bladder penetration and was complicated by a low rate of postoperative outlet obstruction. The midterm therapeutic results and the cost-effectiveness of the TVT obturator appear similar to previously reported midurethral sling operations. Long-term comparative data collection is required to enable drawing solid conclusions regarding the appropriate position of this operative technique within the spectrum of antiincontinence operations. SN - 1553-4650 UR - https://www.unboundmedicine.com/medline/citation/18262152/Tension_free_vaginal_tape_obturator:_midterm_data_on_an_operative_procedure_for_the_cure_of_female_stress_urinary_incontinence_performed_on_100_patients_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1553-4650(07)01201-0 DB - PRIME DP - Unbound Medicine ER -